Singapore- The meetings hub for health sciences
For the past two years, Singapore has demonstrated leadership in safeguarding public health during the Covid-19 pandemic. Singapore has continued to deliver successful events owing to the region’s proactive Covid-19 response and development of cutting-edge solutions to meet the challenges presented by the spread of the virus.
Proactive, forward-thinking leadership and a calibrated approach have been instrumental in the success of business events in Singapore.
Regional leader in tackling Covid-19
When Covid-19 became a concern, Singapore took a proactive stance in tackling the pandemic back in March 2020. Singapore released TraceTogether, becoming the first country in the world to implement a Covid-19 contact tracing app . The country also developed enhanced measures for cleanliness and hygiene, such as autonomous UV-disinfecting robots which have been used in public areas. With such measures in place, Singapore has been able to effectively identify and isolate Covid-19 clusters and keep locally transmitted cases under control.
Singapore is quick to support the evolving global Covid-19 situation, through its health sciences industry, thanks to their manufacturing capabilities, pro-business environment, as well as commitment to innovation and research in the biomedical and health domain. For example, set to be operational in 2022, Thermo Fisher Scientific announced plans to set up a sterile fill-and-finish facility for therapeutics and vaccines in Singapore. This new facility will initially include a high-speed sterile line approved for live virus filling – the first such large scale capability in Singapore – followed by an additional line for standard fill-and-finish . The facility will be able to manufacture up to 30million sterile doses per month and employ more than 300 people.
In addition to these pharmaceutical manufacturing initiatives, Singapore’s central location in the region and world-class port infrastructure facilities make it a suitable vaccine distribution hub.
Singapores’s Pharma@Changi initiative offers extensive capabilities, efficiency, and reliability, all brought together through a partnership that covers the entire airfreight supply chain, forming the largest IATA CEIV Pharma airport community in Asia Pacific. Through this collaboration, Singapore will be able to position itself as the premier location for layovers in vaccine transportation in the APAC region.
Singapore – a leader in public health events
Singapore’s status as a health sciences innovation hub and the high concentration of top healthcare companies in the country make it an ideal location to host business events where industry players can gather to build networks and collaborate.
Singapore is in a prime location to provide innovative connections throughout the region. Singapore readily connects policymakers, academics, and health sciences professionals through a variety of conferences and thought leadership events that cover both niche topics and wider industry concerns.
One such example is the of this connectivity is the seventh World One Health Congress, 7-11 November 2022. It’ is seen as the world’s premier conference for the worldwide One Health community. The bi-annual event comprises a mix of lectures, debates, workshops and symposia, targeted at One Health advocated, researchers, scientists, health professionals, disease control experts and zoologists.
The theme for this year’s World One Health Congress is Integrating Science, Policy and Clinical Practice: A One Health Imperative Post Covid-19. Further details to be found here.
Furthermore, highlighting the importance Singapore plays in hosting events for health professionals, the region has held and secured several pertinent events:
Recently held was the Asia Pacific Congress of Clinical Microbiology and Infection (APCCMI) 2021 – , one of Asia’s top infectious diseases congresses. Also, the annual Asia Pacific MedTech Forum, held last September, provided a unifying voice for the medical devices and in-vitro diagnostics industry.
All these events bring together top talent in the pandemic control, infectious diseases and medical technology sectors to discuss and develop critical solutions for the world’s biggest healthcare challenges – Covid-19 and beyond. The selection of Singapore as the host location for these events demonstrates the country’s reputation as a global hub for biomedical sciences throughout Asia. All these events bring together top talent in the pandemic control, infectious diseases and medical technology sectors to discuss and develop critical solutions for the world’s biggest healthcare challenges – Covid-19 and beyond.
To find out more on the applied health sciences industry in Singapore, please click here.